Skip Navigation

AIDSInfo-at-a-glance

Issue No. 1 | January 8, 2016
A Service of the U.S. Department of Health and Human ServicesView HTML version
News and Features 

Scientific/Clinical Member Nominations are Now Being Accepted for the Department of Health and Human Services (HHS) Panel on Antiretroviral Guidelines for Adults and Adolescents

The HHS Panel on Antiretroviral Guidelines for Adults and Adolescents (or the Panel) is accepting nominations for new scientific/clinical members with expertise in HIV medicine. The Panel is seeking candidates with expertise in any of the following areas of HIV clinical research and clinical care: adolescent medicine, biostatistics, HIV drug resistance, and hepatitis coinfection. Individuals who served as Panel members in the past are welcome to reapply.

Panel members critically evaluate new information and prepare guidelines revisions. The candidates should be recognized experts in their areas of interest. The successful candidates will serve a 4-year term beginning April 2016, with potential for reappointment for an additional term.

The Panel is a Working Group of the Office of AIDS Research Advisory Council of the National Institutes of Health. The Panel is composed of over 40 members who are clinicians, researchers, academicians, HHS representatives, and community representatives with expertise in HIV management in the United States. The Panel meets monthly via teleconferencing and annually in a face-to-face meeting to review and critically evaluate emerging scientific data relating to antiretroviral therapy and revise the Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. The latest guideline was published on April 8, 2015, and can be found at https://aidsinfo.nih.gov/. 

Panel members are not financially compensated for their time commitment. 

The nomination should include a curriculum vitae and a letter of interest or a letter of nomination (from a colleague) with specific reference to how the nominee would contribute to the work of the Panel. Self-nomination is welcome. All supporting documents should be submitted to Alice Pau, Pharm.D. electronically (apau@niaid.nih.gov) by no later than January 25, 2016.
 

Community Member Nominations are Now Being Accepted for the Department of Health and Human Services (HHS) Panel on Antiretroviral Guidelines for Adults and Adolescents

The HHS Panel on Antiretroviral Guidelines for Adults and Adolescents (or the Panel) is accepting nominations for a new community representative to serve a 4-year term beginning April 2016 with potential for reappointment for one additional term. Individuals who served as Panel members in the past are welcome to reapply. The Panel welcomes diversified representation in the community membership reflecting the demographics of the current HIV epidemic in the United States. The community member may assist the Panel in identifying and addressing unique treatment aspects that relate to the constituency he/she represents. The candidate shall have knowledge and involvement in issues related to management of HIV-infected adults and adolescents, as evidenced by experience in HIV treatment education/advocacy or clinical/public policy initiatives related to HIV treatment. 

The Panel is a Working Group of the Office of AIDS Research Advisory Counsel of the National Institutes of Health. The Panel is composed of over 40 members who are clinicians, researchers, academicians, HHS representatives, and community representatives with expertise in HIV management in the United States. The Panel meets monthly via teleconferencing and annually in a face-to-face meeting to review and critically evaluate emerging scientific data relating to antiretroviral therapy and revise the Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. The guideline is a living document that can be found at https://aidsinfo.nih.gov/. The last revision was released on April 8, 2015. 

Panel members are not compensated for their time commitment.

The nomination should include a resume and a letter of nomination or a letter of interest with specific reference as to how the nominee would contribute to the work of the Panel. Self-nomination is welcome. All supporting documents should be submitted to Alice Pau, Pharm.D. electronically (apau@niaid.nih.gov) by no later than January 25, 2016.

Home | Guidelines | Clinical Trials | Drugs | Health Topics | Education Materials | Mobile Resources & Tools
Contact Us
Left footer corner image Left footer corner image